US Stock MarketDetailed Quotes

FULC Fulcrum Therapeutics

Watchlist
  • 7.140
  • +0.010+0.14%
Close Apr 26 16:00 ET
  • 7.140
  • 0.0000.00%
Post 16:00 ET
443.78MMarket Cap-4490P/E (TTM)

Fulcrum Therapeutics Key Stats

Fulcrum Therapeutics Earnings Date

Currency: USD

Period

Q4 FY2023 Earnings

Feb 27, 2024

Revenue(YoY)

871.00K

+27.15%
EPS(YoY)

-0.40

+20.00%

Strong Buy

Apr 25, 2024

Fulcrum Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 371.710K--
--2024/Q1-- / 360.140K--
Feb 27, 20242023/Q4871.000K / 394.800K--
Nov 7, 20232023/Q3759.000K / 1.052M--
Aug 3, 20232023/Q2880.000K / 956.850K--
May 15, 20232023/Q1295.000K / 980.640K--
Mar 9, 20232022/Q4685.000K / 1.890M--
Nov 8, 20222022/Q31.183M / 2.543M--
Aug 11, 20222022/Q21.882M / 2.964M--
May 9, 20222022/Q12.592M / 3.944M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q2-- / 371.710K--
--2024/Q1-- / 360.140K--
Feb 27, 20242023/Q4871.000K / 394.800K--
Nov 7, 20232023/Q3759.000K / 1.052M--
Aug 3, 20232023/Q2880.000K / 956.850K--
May 15, 20232023/Q1295.000K / 980.640K--
Mar 9, 20232022/Q4685.000K / 1.890M--
Nov 8, 20222022/Q31.183M / 2.543M--
Aug 11, 20222022/Q21.882M / 2.964M--
May 9, 20222022/Q12.592M / 3.944M--

Unlock Free Earnings Estimates

Fulcrum Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Apr 25, 2024

Strong Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg